I kliniske studier var forekomsten af hypoglykæmi 1, 2%, når 50 mg vildagliptin én gang daglig blev kombineret med glimepirid mod 0, 6% for placebo + glimepirid.
In clinical trials, the incidence of hypoglycaemia when vildagliptin 50 mg once daily was added to glimepiride was 1.2% versus 0.6% for placebo + glimepiride.